Terms: = Colorectal cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
18 results:
1. Associations of dietary factors and xenobiotic intake with faecal microbiota composition according to the presence of intestinal mucosa damage.
Ruiz-Saavedra S; González Del Rey C; Suárez A; Díaz Y; Zapico A; Arboleya S; Salazar N; Gueimonde M; de Los Reyes-Gavilán CG; González S
Food Funct; 2023 Oct; 14(21):9591-9605. PubMed ID: 37740374
[TBL] [Abstract] [Full Text] [Related]
2. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
Xu L; Cai Y; Chen X; Zhu Y; Cai J
BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
[TBL] [Abstract] [Full Text] [Related]
3. The Novel Target of colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of cxcr4/NF-κB Signaling.
Kou T; Sha D; Wang F; He T; He X
Cell Biochem Biophys; 2021 Mar; 79(1):113-121. PubMed ID: 33151473
[TBL] [Abstract] [Full Text] [Related]
4. ERK1/2 Signaling Induces Upregulation of ANGPT2 and cxcr4 to Mediate Liver Metastasis in Colon cancer.
Urosevic J; Blasco MT; Llorente A; Bellmunt A; Berenguer-Llergo A; Guiu M; Cañellas A; Fernandez E; Burkov I; Clapés M; Cartanà M; Figueras-Puig C; Batlle E; Nebreda AR; Gomis RR
Cancer Res; 2020 Nov; 80(21):4668-4680. PubMed ID: 32816905
[TBL] [Abstract] [Full Text] [Related]
5. Circ_0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating cxcr4 and VEGF-A in colorectal cancer.
Zheng X; Ma YF; Zhang XR; Li Y; Zhao HH; Han SG
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4190-4202. PubMed ID: 32373955
[TBL] [Abstract] [Full Text] [Related]
6. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic colorectal cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract] [Full Text] [Related]
8. Long-Term Outcome of whim Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.
Dotta L; Notarangelo LD; Moratto D; Kumar R; Porta F; Soresina A; Lougaris V; Plebani A; Smith CIE; Norlin AC; Gòmez Raccio AC; Bubanska E; Bertolini P; Amendola G; Visentini M; Fiorilli M; Venuti A; Badolato R
J Allergy Clin Immunol Pract; 2019; 7(5):1568-1577. PubMed ID: 30716504
[TBL] [Abstract] [Full Text] [Related]
9. Role of cxcr4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract] [Full Text] [Related]
10. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variants associated with colorectal brain metastases susceptibility and survival.
Stremitzer S; Berghoff AS; Volz NB; Zhang W; Yang D; Stintzing S; Ning Y; Sunakawa Y; Yamauchi S; Sebio A; Matsusaka S; Okazaki S; Hanna D; Parekh A; Mendez A; Berger MD; El-Khoueiry R; Birner P; Preusser M; Lenz HJ
Pharmacogenomics J; 2017 Jan; 17(1):29-35. PubMed ID: 26689941
[TBL] [Abstract] [Full Text] [Related]
12. Prognosis and Clinicopathology of cxcr4 in colorectal cancer Patients: a Meta-analysis.
Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
[TBL] [Abstract] [Full Text] [Related]
13. cxcr4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.
Tamas K; Domanska UM; van Dijk TH; Timmer-Bosscha H; Havenga K; Karrenbeld A; Sluiter WJ; Beukema JC; van Vugt MA; de Vries EG; Hospers GA; Walenkamp AM
Curr Pharm Des; 2015; 21(17):2276-83. PubMed ID: 25557636
[TBL] [Abstract] [Full Text] [Related]
14. Intracellular cxcr4⁺ cell targeting with T22-empowered protein-only nanoparticles.
Unzueta U; Céspedes MV; Ferrer-Miralles N; Casanova I; Cedano J; Corchero JL; Domingo-Espín J; Villaverde A; Mangues R; Vázquez E
Int J Nanomedicine; 2012; 7():4533-44. PubMed ID: 22923991
[TBL] [Abstract] [Full Text] [Related]
15. Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo.
Tang J; Zhang L; She X; Zhou G; Yu F; Xiang J; Li G
Cancer Invest; 2012 Jun; 30(5):380-9. PubMed ID: 22409183
[TBL] [Abstract] [Full Text] [Related]
16. Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma.
Xu H; Wu Q; Dang S; Jin M; Xu J; Cheng Y; Pan M; Wu Y; Zhang C; Zhang Y
PLoS One; 2011; 6(12):e27399. PubMed ID: 22180778
[TBL] [Abstract] [Full Text] [Related]
17. Imaging cxcr4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.
De Silva RA; Peyre K; Pullambhatla M; Fox JJ; Pomper MG; Nimmagadda S
J Nucl Med; 2011 Jun; 52(6):986-93. PubMed ID: 21622896
[TBL] [Abstract] [Full Text] [Related]
18. Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings.
Della Porta M; Danova M; Rigolin GM; Brugnatelli S; Rovati B; Tronconi C; Fraulini C; Russo Rossi A; Riccardi A; Castoldi G
Oncology; 2005; 68(2-3):276-84. PubMed ID: 16015045
[TBL] [Abstract] [Full Text] [Related]
